This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
rhTβ4 treatment was significantly more effective than ketoconazole in improving scalp conditions.
Why it matters
Finding effective treatments for seborrheic dermatitis is crucial since current options are limited. This research highlights a new potential therapy that not only alleviates symptoms but also restores scalp microbiome balance.
How the study worked
The study involved a 4-week treatment of 71 SD patients with rhTβ4 gel or ketoconazole lotion, comparing clinical and physiological outcomes.
What this study cannot tell us
The study's sample size, while significant, may limit the generalizability of the findings, and long-term effects of rhTβ4 require further investigation.
Read the original research
Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.
Microbial biotechnology, 14(5), 2152-2163
Citation
Yu, Rui; Lin, Qingbin; Zhai, Yanfang; Mao, Yunyun; Li, Kai; Gao, Yuemei; Liu, Yanhong; Fu, Ling; Fang, Ting; Zhao, Mengsu; Guan, Lei; Hou, Lihua; Xu, Junjie; Chen, Wei. (2021). Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.. Microbial biotechnology, 14(5), 2152-2163. https://doi.org/10.1111/1751-7915.13897